A woman in her late 30s has died of a rare blood clotting condition nearly two weeks after receiving a single-dose Johnson & Johnson COVID-19 vaccine in Washington, according to state health officials. The woman is the first confirmed death in King County, and the fourth person to die nationwide out of the nearly 15 … Read moreFourth woman dead from rare clots after Johnson and Johnson vaccine administered
Pfizer and BioNTech’s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of kids ages 5 to 11, the drugmakers announced Monday. The companies tested a two-dose regimen of 10 micrograms — about a third the dosage used for teens and adults — administered three weeks apart. They said the shots were … Read morePfizer set to submit to FDA: Covid vaccine ‘safe’ in kids
MORE.. After several people had apparent allergic reactions at one California clinic, state health officials on Sunday told providers across the state to pause administering doses from one COVID-19 vaccine lot that arrived from Moderna. The move, made “out of an extreme abundance of caution,” means that 330,000 doses distributed to 287 providers across the … Read moreCalifornia pauses Moderna vaccine at one location after allergic reactions
ABC NEWS reports that four workers had elevated heart rates and “tingling” .. MORE.. Officials are stating it is a normal side effect.. MORE: Advocate Aurora Health, a health care system in Wisconsin and Illinois, said Friday that it paused COVID-19 vaccinations after health care workers “experienced reactions” from the Pfizer shot. Four team members … Read moreILLINOIS MEDICAL CENTER PAUSES PFIZER VACCINES AFTER REACTIONS REPORTED
AstraZeneca said it plans to conduct a new global clinical trial to assess the Oxford-AstraZeneca vaccine’s efficacy. The news comes after the company and the university acknowledged a dosing error in trials. More: In a statement Wednesday, Oxford University said some of the vials used in the trial didn’t have the right concentration of vaccine … Read moreFlash: AstraZeneca will conduct new global vaccine trial after error!
The company released a statement on Monday, saying “We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 Ensemble trial, due to an unexplained illness in a study participant.” The vaccine was being tested in 60,000 participants across the US, Argentina, Brazil and several other countries. In … Read moreVaccine test paused at Johnson and Johnson